Safety was evaluated by recording all adverse events , efficacy by the St George 's Respiratory Questionnaire ( SGRQ ) as primary endpoint , and pulmonary function testing , modified Medical Research Council dyspnoea score ( mMRC ) and 6-min walk distance ( 6MWD ) up to 12months after the final treatment .